12^th International Conference on Preventive Medicine & Public Health November 23-24, 2020 London, UK

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Prof. Dr. Carol Thomson, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Genetics, Virology and Immunology at California South University (CSU), Irvine, California, USA. He is a British scientist, who along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, co-discovered Hepatitis B in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis B led to the rapid development of diagnostic reagents to detect HCV in blood supplies which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide. Prof. Dr. Carol Thomson is currently America Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the California South University (CSU) where he is also Director of the Li Ka Shing Applied Virology Institute.

Genetics, Health Care, Medicine

Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, and then his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was being a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Chair of the Dept for Clin Immunology, Moscow Clin Research Institute (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor, Director, Center for Personalized Medicine, Sechenov University and Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● European Association for Medical Education (AMEE), Dundee, UK; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● Personalized Medicine Coalition (PMC), Washington, DC, USA Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”

Personalized and Precision Medicine,Translational Medicine, Preventive Medicine

XUE-QIAO ZHAO, is a Research Professor of Medicine and Director of Coronary Atherosclerosis Research Laboratory, University of Washington. She was a Senior Research Fellow, Cardiology, University of Washington, Seattle, WA, 1993. She was also Research Fellow, Cardiovascular Laboratory, Tulane University School of Medicine, New Orleans, LA, 1989. She was Chief Resident, Cardiology, Beijing Medical University, Beijing, China, 1988 and Cardiology Fellow, Beijing Medical University, Beijing, China, 1988. She was Resident in Internal Medicine, Beijing Post-Telecommunications Hospital, Beijing Medical University, Beijing, China, 1986.S he has completed MD, Beijing Medical University, Beijing, China, 1983.

Medicine

Dr. Masako Morishita is an Associate Professor in the Department of Family Medicine, College of Human Medicine at Michigan State University (MSU). She is an environmental exposure scientist, focused on improving physicochemical characterization of indoor/outdoor airborne particles, quantification of biomarkers of trace metals, and emission source identification – all of which is essential for toxicological and epidemiological studies in public health. Until recently she led exposure assessment tasks in the Great Lakes Air Center for Integrated Environmental Research (funded by USEPA), and directed the Trace Metals Laboratory for the University of Michigan Environmental Health Sciences Core Center (funded by NIEHS). She now directs the newly-constructed MSU Exposure Science Laboratory. She is currently the PI of an NINR R01 project, conducting a community-based intervention study focusing on the reduction of personal PM2.5 exposure and adverse cardiovascular responses. She received her B.S. in chemical engineering and her M.S. and Ph.D. in environmental health sciences from the University of Michigan.

Environmental Health Science, Preventive Medicine, Health Care